Brought to you by:
Paper The following article is Open access

Synthesis and characterization of chitosan-coated magnetite nanoparticles and their application in curcumin drug delivery

, , , and

Published 13 October 2016 © 2016 Vietnam Academy of Science & Technology
, , Citation Xuan Nui Pham et al 2016 Adv. Nat. Sci: Nanosci. Nanotechnol. 7 045010 DOI 10.1088/2043-6262/7/4/045010

2043-6262/7/4/045010

Abstract

In this work anti-cancer drug curcumin-loaded superparamagnetic iron oxide (Fe3O4) nanoparticles was modified by chitosan (CS). The magnetic iron oxide nanoparticles were synthesized by using reverse micro-emulsion (water-in-oil) method. The magnetic nanoparticles without loaded drug and drug-loaded magnetic nanoparticles were characterized by XRD, FTIR, TG-DTA, SEM, TEM, and VSM techniques. These nanoparticles have almost spherical shape and their diameter varies from 8 nm to 17 nm. Measurement of VSM at room temperature showed that iron oxide nanoparticles have superparamagnetic properties. In vitro drug loading and release behavior of curcumin drug-loaded CS-Fe3O4 nanoparticles were studied by using UV-spectrophotometer. In addition, the cytotoxicity of the modified nanoparticles has shown anticancer activity against A549 cell with IC50 value of 73.03 μg/ml. Therefore, the modified magnetic nanoparticles can be used as drug delivery carriers on target in the treatment of cancer cells.

Export citation and abstract BibTeX RIS

Original content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.

1. Introduction

Chemotherapy is not specialized to a certain treatment, which is the most notable drawback of this therapy method. When drug goes into the body, the medicine does not concentrate mainly on the diseased cells. Hence, magnetic particles are recently used to carry the drugs to the required location in the body, typically cancer tissues. The method of using superparamagnetic iron oxide nanoparticles has received much attention from the research community with two main objectives: (i) to narrow the distribution of drugs in the body for reducing the side effects; (ii) to reduce the amount of drug consumption.

The biocompatible magnetic nanoparticles are encapsulated with drugs. They work as drug delivery carriers and control the drug release process. Therefore, the application of superparamagnetic iron oxide nanoparticles in diagnosis and therapeutics has gained many promising achievements such as cell separation [1], cell apoptosis [2], and enzyme immobilisation [3]. Generally, the drug–particle system creates a magnetic liquid and enters the body via the circulatory system. When the particles enter the blood vessel, a strong external magnetic field gradient is used to guide the particles to arrive at the targeted location in the body. When the drug–particle system is concentrated at the required location, the drug release process is taken place by enzyme activity or physiological property change of cancer cells causing the variation of pH, diffusion, and temperature. Drug carried by magnetic nanoparticles can easily be directed to a targeted location in the body by magnetic force [4, 5]. Meanwhile, the polymer coated drug can delay the releasing speed. Therefore, the magnetic nanoparticles coated polymer system are considered to be an effective method to target the cancer cells.

The magnetic material is iron oxide covered by organic or inorganic molecules which form chemical bonds with the surface of Fe3O4 nanoparticles. Iron oxide core particles are nanometer-size superparamagnetic particles. Modified magnetic nanoparticles have been studied by different researchers [6, 7] using 3-aminopropyl triethoxy silane (APTES) coated by nano-carrier through adsorption or covalent bond creating active amino groups to carry anti-cancer drugs. Yao et al [8] prepared magnetic Fe3O4/SiO2-GO core/shell nanoparticles by means of covalent and used as adsorbent. Their results show that this material has a relatively high adsorption ability. In another study, Peng et al [9] reported a simple method to synthesize mesoporous nanoparticles of core–shell structure Fe3O4-@mZnO to use as drug delivery carriers.

Curcumin, an anti-cancer drug, is derived from phenol which is connected by two α, β-unsaturated carbonyl groups. The diketones form stable enols and are readily deprotonated to form enolates. The α, β-unsaturated carbonyl group is a good michael acceptor and undergoes nucleophilic addition. Therefore, they are biologically characterized as antioxidant [10], anti-inflammatory [11], antibacterial [12], and antitumor activity [13]. However, solubility of curcumin in water is low, unstable and the short half-life cycles of in vitro metabolism limited its clinical application. To increase the solubility in water and biological compatibility of curcumin, different carriers were tested to encapsulate drug in polymer micelles [14], solid-lipid particles [15], and nano-polymeric particles [16].

Among the available polymers, natural chitosan shows some promising results in drug delivery system. Chitosan (CS), the second most naturally abundant polymer after cellulose, is a natural bio-polymer derived from alkaline deacetylation of chitin. Due to its chemical structure and the non-toxic nature [17], CS has received much attention and used widely in many fields such as adsorbent [18] and anti-bacterial membrane [19]. In some recent applications, CS is often used in drug delivery system [2022] and protein carriers [23].

Many different methods have been investigated to synthesize magnetic nanoparticles such as co-precipitation, sol-gel process, micro-emulsion, ultrasonic chemistry, hydrothermal, hydrolysis, thermolysis, and flow injection method. The formation of nanoparticles depends on the synthetic method. Micro-emulsion method has high capability to disperse Fe3O4 nanoparticles in a solution and particle size can be well controlled by the surfactant.

In this study, superparamagnetic Fe3O4 nanoparticles were synthesized by micro-emulsion method used as carriers. The carrier was coated as chitosan to create a polymeric shell to form an active amino group on its surface to be able to combine with the anti-cancer curcumin (Cur) drug. The morphology, structure, and characteristic of iron oxide nanoparticles coated with CS solution were studied by x-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), differential thermal analysis (DTA), and vibrating sample magnetometer (VSM). The application of chitosan-loaded magnetic nanoparticles (CS-MNPs) as carrier of Cur was evaluated by loading and releasing profiles and in vitro cytotoxicty.

2. Experimental

2.1. Materials

Iron (III) chloride hexahydrate (FeCl3.6H2O), iron (II) sulfate heptahydrate (FeSO4.7H2O), ammonium hydroxide (28% w/w NH3), chitosan (C6H11NO4)n with deacetylation degree of 86%, MW = 60 kDa, glass acetic acid, butanol (C4H9OH), tween-80, heptane, cetyl trimethylammonium bromide (CTAB), and curcumin were purchased from E-Merck Products. All other reagents were analytical grade and used directly without any purification, and A549 (human lung carcinoma cell line) cell was provided by the University of Milan, Italy.

2.2. Synthesis of magnetic Fe3O4 nanoparticles

The Fe3O4 magnetic nanoparticles were prepared by water-in-oil micro-emulsion method. The precursor solution (solution A) contains 2:1 mole ratio of iron salts (10 ml of 0.4 M FeCl3.6H2O and 10 ml of 0.2 M FeSO4.7H2O) dissolved in 45 ml mixture of tween-80/butan-1-ol/n-heptane. This resulted in the formation of a reverse micro-emulsion. Mixture B contains 45 ml of tween-80/butan-1-ol/n-heptane added to aqueous NH3 (56 ml of 28% aqueous NH3). These solutions were stirred with speed of 300 rmp/min for 30 min at room temperature. Mixture B was added to solution A and the combined mixture was stirred continuously with a rotational speed of 1000 rpm for 24 h at different temperatures were 30, 50, and 80 °C. Formed magnetic nanoparticles were separated by magnetic force and washed several times by distilled water to eliminate the ammonia. Finally, the magnetic Fe3O4 nanoparticles were obtained after drying in a vacuum oven, and recorded as Fe3O4-30, Fe3O4-50, and Fe3O4-80, respectively.

2.3. Synthesis of chitosan-coated magnetic Fe3O4 nanoparticles

The surface of magnetic Fe3O4 nanoparticles was coated with a solution of CS for the purpose of obtaining modified magnetic nanoparticles. In a typical experiment, 0.25 g of magnetic Fe3O4 nanoparticles was dispersed in a surfactant containing CTAB (2 grams of CTAB dissolved in 400 ml of deionized water) (solution C). Then, 100 ml chitosan solution (0.02 gram CS powders dissolved in 100 ml of 1% (w/v) acetic acid solution) was slowly dropped into solution C. The mixture was continuously stirred with a rotational speed of 1000 rpm for 1 h at room temperature. Then, CS coated by magnetite nanoparticles was magnetically separated from solution by a magnet bar and thoroughly washed several times with ethanol and deionized water. Finally, the obtained nanoparticles were dried overnight at 60 °C.

2.4. Characteristics of materials

Powder x-ray diffraction patterns were recorded on a D8-Advance Bruker with Cu-Kα radiation (λ = 1.5406 nm). Morphological analysis was examined on a Hitachi S-4800 scanning electron microscope (SEM). The images of TEM were taken by a JEM-1010 (Jeol, Japan) operated at an accelerating voltage of 200 kV. Infrared data were examined on KBr pallets by using a Shimadzu IR Prestige-21 spectrometer (Japan). TGA and DTA were performed with a TG Setaraminstrument (France) in the air of argon (100–1000 °C). The magnetization of the prepared nanoparticles was measured on a VSM (DMS-88) at room temperature.

UV–vis and UV–vis-diffuse reflectance spectra were collected on a DR–Jasco V630 or a UV–vis DRS–Jasco V670 spectrophotometer that was equipped with a diffuse reflectance attachment in which BaSO4 was the reference.

2.5. In vitro curcumin drug loading and release experiments

Anti-cancer curcumin drug was loaded on magnetic Fe3O4 nanoparticles coated by chitosan (CS). Loading of curcumin was performed by dispersing 0.3 gram of chitosan-coated magnetic Fe3O4 nanoparticles (CS-Fe3O4) nanoparticle in 0.1% curcumin solution (dissolved in ethanol) and stirred for 3 h to increase the uptake of curcumin. At each fixed period of time, the magnetic nanoparticles were separated from the mixture by using a magnet. The absorbance of the residual curcumin in the supernatant was measured at λmax = 428 nm by UV–vis spectrophotometer to determine the drug concentration of curcumin. The curcumin loading was determined from the difference between the initial concentration of curcumin in solution and concentration of curcumin in the supernatant solution after the set time interval.

The release profile of the curcumin drug studied in phosphate buffered saline (PBS) at pH of 7.4. 0.3 g of Cur-CS-Fe3O4 was dispersed in PBS at 37 °C and shaking slightly at a rate of 150 cycles/min. At each time intervals, the concentration of curcumin release in the PBS was analyzed by UV–vis spectrophotometer.

2.6. In vitro cytotoxicity assay

A549 cancer cell lines were cultured as monolayers in the culture medium of Dulbecco's modified eagle medium (DMEM) along with other components including 2 mM L-glutamine, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 1.0 mM sodium pyruvate. 10% fetal bovine serum (FBS, Gibco) was also added. The cells were cultured and moved after 3–5 days with a ratio of 1:3 and cultured in CO2 incubator at 37 °C with 5% CO2. Monks's method [24] was implemented for vitro cytotoxicity. The test was conducted to determine the amount of total cell protein based on the optical density (OD) measured the protein components of the cell stained with the sulforhodamine B (SRB). 20 μl of the A549 cells diluted in 10% of dimethyl sulfoxide (DMSO) was put into the standard 96-well plates to obtain different concentrations of 100 μg ml−1, 20 μg ml−1, 4 μg ml−1, and 0.8 μg ml−1. Trypsinized cells were used to separate and count cells in the counting chamber to obtain a suitable experimental density. A suitable number of cells was added to the wells (in 180 ml medium) and so they can develop within 3–5 days. Other 96-well plates without the A549 cells containing 180 μl cancer cells were used to control day 0. After 1 h, the cells in the control plate of day 0 were immobilized by trichloracetic acid (TCA). After a period of development in the CO2 incubator, the cells were immobilized to the bottom of the well by TCA and stained by SRB in 1 h at 37 °C. After removing the SRB, the experimental wells were washed 3 times with acetic acid and dried by air at room temperature.

Finally, 10 mM unbuffered tris base was used to dissolve the SRB sticking on the protein molecules. The system was put on a shaker plate shaking gently for 10 min Then, elisa plate reader (bio-rad) was used to read the color content of the SRB through UV–vis at λmax = 540 nm. The cell viability (%) was related to the control wells containing untreated cells with fresh cell culture medium. The cell viability was calculated by the following formula:

3. Results and discussion

3.1. Characterization of prepared nanoparticles

3.1.1. X-ray diffraction

Figure 1 shows the results of x-ray diffraction (XRD) analysis for magnetic iron oxide nanoparticles synthesized by micro-emulsion method at different temperatures (30 °C, 50 °C and 80 °C). The Fe3O4 diffraction patterns have six main peaks at 2θ values of 30.1°, 35.5°, 43.2°, 53.5°, 57°, and 62.8° corresponding to the reflection from (220), (311), (400), (422), (511), and (440) crystal planes. Positions and relative intensities of all the peaks are in accordance with the cubic crystalline system of Fe3O4 nanoparticles. Patterns of iron oxides and oxyhydroxide products of the JCPDS card. no. 79-0418 database were included for comparison. The narrow shape peaks of materials indicate that the nanoparticles have relatively high crystallinity, and without the appearance of the impurities phase of goethite α-FeO(OH) and hematite (Fe2O3) corresponding to the diffraction peaks of (110), (104) at 2θ positions of 21.22° and 33.15°.

Figure 1.

Figure 1. XRD patterns of (a) magnetic Fe3O4-30, (b) Fe3O4-50 and (c) Fe3O4-80 nanoparticles.

Standard image High-resolution image

Broadness of the diffraction peaks was related to particle sizes. Scherrer's equation

was used to calculate the average particle size D. In this equation θ is the angle of the peak, β is the full width at half maximum (FWHM) of the respective XRD peak, λ is the x-ray radiation wave-length in angstroms, and k is a constant. The broadening of Bragg's peaks indicates the formation of nanoparticles. The calculated mean crystallite size of the Fe3O4 nanoparticles synthesized by micro-emulsion method with three different temperatures 30 °C, 50 °C and 80 °C was about 8.5, 16.7 and 25 nm, respectively. The magnetic Fe3O4 nanoparticles synthesized at 30 °C is used for further studies.

The XRD analysis results for samples of magnetic Fe3O4 nanoparticles coated by chitosan (CS-Fe3O4) and CS-Fe3O4 loaded by curcumin (curves b and c in figure 2, respectively) showed characteristic peaks for Fe3O4 corresponding to the crystal planes of (220), (311), (422), (511), (440), which revealed that after surface modification, nanoparticles were pure Fe3O4 with a cubic structure.

Figure 2.

Figure 2. XRD patterns of (a) uncoated Fe3O4, (b) CS-Fe3O4 and (c) Cur-CS-Fe3O4 nanoparticles.

Standard image High-resolution image

3.1.2. FTIR spectra analysis

FTIR was performed to confirm the functional groups on surface of the synthetic materials. The spectra of pure Fe3O4, CS-Fe3O4 and Cur-CS-Fe3O4 were shown in figure 3. The presence of two strong absorption bands of all materials at around 636 and 592 cm−1 shows the formation of magnetic nanoparticles. Moreover, the band at 592 cm−1 was confirmed as the Fe-O stretching vibration of tetrahedral sites of spinel structure [25]. The absorption bands at 459 cm−1, attributed to tetrahedral and octahedral sites [26], peaks at 3400 cm−1 due to the O-H stretching model adsorbed on the surface of the Fe3O4 nanoparticles [27].

Figure 3.

Figure 3. FTIR spectra of (a) uncoated Fe3O4, (b) chitosan coated Fe3O4 (CS-Fe3O4) and (c) curcumin loaded CS-Fe3O4 nanoparticles.

Standard image High-resolution image

In the case of CS coated magnetic Fe3O4 nanoparticles (curve b in figure 3), the coating of CS is established by the appearance of the peak at 2922 cm−1 considered to be the stretching vibrations of –CH– in chitosan. The peak at 1641 cm−1 is relevant to the N–H vibration for the chitosan. In addition, the C-N vibration of amino group is at 1415 cm−1 and the C–O in the ether group is at 1074 cm−1. The comparison of the spectra of Cur-CS-Fe3O4 with those of CS-Fe3O4 and Fe3O4, shows that the peak at 1510 cm−1 and the band at 1627 cm−1 is attributed to the C–C stretching vibration of the aromatic ring. This indicates the presence of aromatic CH bending vibration.

On the other hand, the appearance of two strong bands at about 1250 and 1040 cm−1 (curve c in figure 3) was confirmed as vibration of methyl phenyl ether group (C-O-CH3) [28]. This suggests that curcumin binds very strongly with chitosan coated magnetic Fe3O4 nanoparticles.

3.1.3. Scanning electron microscopy and transmission electron microscopy analysis

Morphological analysis was studied with electron microscopic images. In the SEM images of Fe3O4 nanoparticles, it can be seen clearly that the particles are uniformly aggregated, spherical shaped with size 8–25 nm (figure 4).

Figure 4.

Figure 4. SEM micrographs of (a) Fe3O4-30; (b) Fe3O4-50; và (c) Fe3O4-80 nanoparticles.

Standard image High-resolution image

SEM images of magnetic uncoated-Fe3O4 nanoparticles, CS-coated Fe3O4 (CS-Fe3O4) nanoparticles and Cur-loaded CS-Fe3O4 are shown in figure 5. The results suggested that all nanoparticles are most spherical in shape and the size of the CS coated Fe3O4, and curcumin-loaded CS-Fe3O4 nanoparticles was in the range from 8–17 nm. From these results, it may prove indirectly that the magnetic core/shell particles remain single crystals to have an average diameter of 8 nm, and the polymer shells have the approximate thickness of 9 nm. The results suggest that the polymer layer is uniformly deposited on Fe3O4 nanoparticles, as shown in figures 5(b) and (c).

Figure 5.

Figure 5. SEM images of (a) uncoated Fe3O4, (b) CS-Fe3O4 and (c) Cur-CS-Fe3O4 nanoparticles.

Standard image High-resolution image

The TEM images in figure 6 of CS-Fe3O4 and Cur-CS-Fe3O4 nanoparticles reveal that the magnetic nanoparticles are spherical in shape, and the average size was 13–17 nm. Thus, the immobilized polymer on nanoparticles did not lead to the aggregation between the particles. This shows the appearance of the bonds on surface of magnetic Fe3O4 nanoparticles.

Figure 6.

Figure 6. TEM images of (a) CS-Fe3O4, and (b) Cur-CS-Fe3O4 nanoparticles.

Standard image High-resolution image

3.1.4. Thermogravimetry differential thermal analysis analysis

The thermal properties of Fe3O4, CS-Fe3O4 and Cur-CS-Fe3O4 were investigated by analytical techniques of TG-DTA. Measurement is conducted under air atmosphere at a heating rate of 10 °C min−1 up to 800 °C. The unloaded Fe3O4 nanoparticles have the initial weight loss of 5.2% in the range of 30–220 °C (curves a in figures 7(A) and (B)). This stage may be the evaporation of water or OH groups adsorbed on the surface of the iron oxide. In the second stage, the weight loss of 3.7% corresponds to the broad exothermic peak at 235 °C (curves b in figures 7(A) and (B)). The cause of this occurrence is due to the oxidation products of Fe3O4 that are easily oxidized to give γ-Fe2O3 particles [29].

Figure 7.

Figure 7. (A) TGA curves and (B) DTA curves for (a) uncoated Fe3O4, (b) CS-Fe3O4 and (c) Cur-CS-Fe3O4 nanoparticles.

Standard image High-resolution image

The weight loss of 12.7% corresponds to the strong exothermic peak at 433 °C (curves c in figures 7(A) and (B)). This shows that the OH groups on the surface of the magnetic nanoparticles are covalently bonded to the NH2 groups in chitosan molecules. Hence, it could infer that the weight loss was the release of hydroxyl ions and decomposition of chitosan on the Fe3O4 nanoparticles except water thermo-desorption. It was also confirmed that the Fe3O4 nanoparticles were successfully coated by chitosan. In addition, the sharp weight loss of 55.1% corresponding to the exothermic peak at 491 °C confirmed the decomposition of carbon skeleton and hydroxyl groups in molecule of curcumin loaded on surface of magnetic CS-Fe3O4 nanoparticles.

3.1.5. Magnetic properties

The magnetization curves of magnetic nanoparticles of Fe3O4, CS-Fe3O4 and Cur-CS-Fe3O4 are given in figure 8. As shown in figure 8, the zero coercivity (Hc = 0) and magnetic remanence (Mr = 0) are observed in all of the magnetic hysteresis curves, which suggest that synthetic materials have superparamagnetic properties. The saturation magnetization (Ms) values of the magnetic Fe3O4, CS-Fe3O4 and Cur-CS-Fe3O4 nanoparticles were 90 emu g−1 and 50 emu g−1 and 18 emu g−1, respectively. The decrease in Ms values of CS-Fe3O4 and Cur-CS-Fe3O4 compared to that of magnetic uncoated Fe3O4 nanoparticle is due to the decrease in particles size. Along with that, the particle size increase is due to the polymer layer coated on the surface of the particles and this also leads to a decrease in the value of magnetic saturation.

Figure 8.

Figure 8. VSM magnetization curves of (a) uncoated Fe3O4, (b) CS-Fe3O4, and (c) Cur-CS-Fe3O4 nanoparticles.

Standard image High-resolution image

The results of vibrating sample magnetometer (VSM) show that all particles have superparamagnetic properties at room temperature since the zero coercivity and the remanence are almost negligible in the absence of an external magnetic field. According to the study by Mohapatra et al [30], Yavuz et al [31], superparamagnetism exhibited in the nanopaticles is due to their size effect (<50 nm). The average particle diameter of prepared samples is smaller than the critical size of superparamatic Fe3O4 at room temperature. The Fe3O4 particles are considered to be at their superparamagnitism. On the other hand, it is considered that the superparamagnetic properties may also be due to the high crystallinity of the prepared spherical shape magnetic nanoparticles.

3.1.6. In vitro drug loading and release studies

Figures 9 and 10 represent the in vitro drug loading and release profile of curcumin from Cur-CS-Fe3O4 nanoparticles. The loading profile (figure 9(b)) shows the rapid adsorption of curcumin in the initial stages and the adsorption rate slowed down after 90 min Because the surface of the nanoparticles is incorporated by curcumin, the final saturation point was reached at 120 min. In addition, the adsorption time of 120 min did not significantly change the concentrations of curcumin because curcumin with the nanoparticles had reached the saturation point. From the results obtained above, it can be concluded that the maximum drug absorption time is short, about 120 min.

Figure 9.

Figure 9. In vitro drug loading of curcumin on CS coated Fe3O4 nanoparticles: (a) absorption spectra and (b) absorption rate at different times.

Standard image High-resolution image
Figure 10.

Figure 10. In vitro drug curcumin release from CS coated Fe3O4 nanoparticles in buffer with pH of 7.4: (a) absorption spectra and (b) absorption rate at different times.

Standard image High-resolution image

Figure 10 depicts the in vitro drug release profile of curcumin from Cur-CS-Fe3O4 nanoparticles at the pH of 7.4 and the release in phosphate buffer solution, at 37 °C.

The UV-spectra of curcumin loaded CS-Fe3O4 nanoparticles dissolved in buffer show an increase in absorbance with the increase in time. However, the release rate is relatively slow when the time was prolonged. The drug release rapidly occurs for the first 180 min. This may be due to the excess of curcumin drug molecules dispersed from matrix of the magnetic nanoparticles into buffer solutions, leading to the drug release at a faster rate [32]. The slow drug release was attributed to the presence of highly soluble phenolic acid groups in ionized drugs and the concentration reduction of chitosan on the surface [33].

About 30% of the un-released curcumin remining on the magnetic nanoparticles matrix for 2800 min may be due to inter-molecular hydrogen bonding of curcumin and also because chitosan has hindered the drug release from the particles [34, 35]. This result is similar to that of the previous study by Ramanujan et al [34]. Drug loading and release profiles of PVA coated iron oxide nanoparticles showed that up to 45% of adsorbed drug was released in 80 h. Thus, the results show that Cur-loaded CS-coated iron oxide nanoparticles are promising magnetic drug carriers to use in magnetically targeted drug delivery.

3.2. In vitro cytotoxicity assay

The cytotoxicity of free Cur and magnetic Cur-CS-Fe3O4 nanoparticles evaluated against A549 cell lines with the concentrations ranging from 6.25 μg ml−1 to 100 μg ml−1 is presented in table 1. It was observed that cell inhibition was decreased at lower concentrations of nanoparticles. That is due to the lower concentrations of drug loaded into nanoparticles. The cancer cells treated with a lower concentration (10 μg ml−1) of the curcumin loaded magnetic Fe3O4 nanoparticles show a low percentage of inhibitions (4.98%) whereas curcumin loaded magnetic nanoparticles with higher concentrations (100 μg ml−1) have a very high ability to inhibit cancer cells (78.55 μg ml−1). With this concentration, the free-curcumin inhibited cancer cells were 94.4%. Because of the slower release rates of curcumin from nanoparticles, it reduces the interaction of the drug with a cell wall.

Table 1.  Cytotoxicity assay of free-curcumin and curcumin loaded CS-Fe3O4 nanoparticles.

  Sample
A549 cell lines concentration (μg/ml) free Cur (% of inhibitions) Cur-CS-Fe3O4 (% of inhibitions)
6.25 11.57 4.98
12.5 69.26 16.39
25 87.5 24.32
50 90.4 31.59
100 94.4 78.55
IC50 11.37 73.03

From the obtained results, table Curve software was used to calculate the IC50 values. IC50 is the drug concentration at which the drug includes 50% inhibition of the growth of the cells. The results obtained from the two samples of free-curcumin and magnetic Cur-CS-Fe3O4 nanoparticle shown the activity on cancer the A549 cell line with an IC50 value of 73.03 and 11.37 μg ml−1, respectively. It suggests that chitosan-coated magnetic nanoparticles have no cytotoxicity at the normal concentration and show a good biocompatibility.

4. Conclusions

Magnetic Fe3O4 nanoparticles are synthesized by a reverse micro-emulsion of water-in-oil. The synthesized magnetic nanoparticles (MNPs) showed relatively small size and good magnetic responsivity. The magnetic carrier was formed by the chitosan-coated MNPs which were characterized by XRD, FTIR, SEM, TEM, TG/DTA, and VSM techniques. TEM results showed that the magnetic nanoparticles have spherical shaped morphology and the average size from 8 to 17 nm. The FTIR and TG/DTA data indicate that the functional groups were successfully attached on surface of the nanoparticles. The outcomes of VSM proved that the un-coated Fe3O4, CS-Fe3O4 và Cur-CS-Fe3O4 nanoparticles have a superparamagnetic characteristic. The in vitro studies of Cur-loaded CS-coated showed up to 70% of adsorbed drug released in the buffer solution after 2800 min The in vitro release profile suggests that Cur-loaded CS-coated Fe3O4 is promising in drug delivery carriers in cancer therapy.

Acknowledgments

This work was sponsored by Vietnam Ministry of Education and Training under the contract no. B2016-DHH-13.

Please wait… references are loading.